Venetoclax and hypomethylating agent combination therapy in newly diagnosed acute myeloid leukemia: Genotype signatures for response and survival among 301 consecutive patients

Naseema Gangat, Omer Karrar, Moazah Iftikhar, Kristen McCullough, Isla M. Johnson, Maymona Abdelmagid, Mostafa Abdallah, Aref Al-Kali, Hassan B. Alkhateeb, Kebede H. Begna, Abhishek Mangaonkar, Antoine N. Saliba, Mehrdad Hefazi Torghabeh, Mark R. Litzow, William Hogan, Mithun Shah, Mrinal M. Patnaik, Animesh Pardanani, Talha Badar, Hemant MurthyJames Foran, Jeanne Palmer, Lisa Sproat, Nandita Khera, Cecilia Arana Yi, Ayalew Tefferi

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Venetoclax and hypomethylating agent combination therapy in newly diagnosed acute myeloid leukemia: Genotype signatures for response and survival among 301 consecutive patients'. Together they form a unique fingerprint.

Medicine & Life Sciences